DrugDashboards

Market view

atropine sulfate injection usp, 0.5 mg/0.7 ml · Injection

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

Same drug class

Other molecules FDA puts in Cholinergic Muscarinic Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Atropine sulfate injection usp, 0.5 mg/0.7 ml in shortage right now?
No. FDA does not currently list Atropine sulfate injection usp, 0.5 mg/0.7 ml in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Atropine sulfate injection usp, 0.5 mg/0.7 ml?
1 company has marketed Atropine sulfate injection usp, 0.5 mg/0.7 ml in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.